| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7449ca99fbf1c556219fe28876cbf2a9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
| filingDate |
2005-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51769c4dc4fb59c360e0ae3475ae2465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a71199dd76451851f4fec8906ce7ad2a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60d391b7e0f79096de5b0883b9ee19e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14156ee27620066b594fdc7d6f4c0855
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ad05bbb7fac7fa7ac2cef794d55cb5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e7387a290570166f61885356a58e213
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_467b9b7fc44979fde22e640e0ca3601a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6bbd5b6bc159fbe9541cbeb51a4dea0 |
| publicationDate |
2006-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1722808-A2 |
| titleOfInvention |
Egf receptor epitode peptides and uses thereof |
| abstract |
The present invention relates generally to growth factor receptor epitope peptides, particularly EGF family receptor epitope peptides. The invention also relates to the use of the receptor peptides in generating antibodies which have anti-tumor or anti-cancer activity or in stimulating an immunological response. The invention further relates to antibodies specifically directed against the receptor peptides. Methods for generating an immune response and for treatment of tumors and cancer are also provided. |
| priorityDate |
2004-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |